NEW YORK (GenomeWeb) – Sygnis today announced that it has raised €5 million ($6.2 million) in a rights offering to German and international institutional investors.

The company said the subscription ratio in the offering was 13:3, meaning 13 existing shares entitled the shareholder to subscribe for three new shares in the firm. The subscription price was €2 per share. Shares that were not subscribed in the rights offering were offered to select German and international institutional investors at the same price.

To read the full story....

Register for Free.

...and receive Daily News bulletins.

Already have an account?
Login Now.

US News & World Report writes that genetic testing of lung tumors can help identify treatments for patients.

A team of researchers plans to sample Loch Ness for environmental DNA, according to Newsweek.

The New York Times writes about the appearance of mosaicism in healthy people.

In PNAS this week: insecticide resistance patterns Anopheles gambiae mosquito, transcriptome patterns in Pseudomonas aeruginosa during infection, and more.